Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze IDNA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate IDNA investment potential.

What is IDNA stock price today?

Get real-time IDNA stock price, historical data, and price charts on Financhill. Track IDNA performance with our advanced analysis tools.

Is IDNA a good investment?

Evaluate IDNA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy IDNA stock?

To buy IDNA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of IDNA?

View detailed market capitalization data and company valuation metrics for IDNA on our comprehensive analysis page.

What is the P/E ratio of IDNA?

Use our fundamental analysis tools to view IDNA P/E ratio and compare valuation metrics with industry peers.

What are IDNA earnings?

View IDNA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

iShares Genomics Immunology and Healthcare ETF 10K Form

Buy

IDNA
iShares Genomics Immunology and Healthcare ETF

Last Price:

$27.00

Seasonality Move:

-1.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IDNA News And Ratings

See the #1 stock for the next 7 days that we like better than IDNA

IDNA Financial Statistics

Sales & Book Value

Annual Sales:	--
Cash Flow:	$0
Price / Cash Flow:	0
Annual Sales:	$0.00
Price / Book:	0

Profitability

Net Income (TTM):	$0
Gross Margin:	--
Return on Equity:	0%
Return on Assets:	0%

iShares Genomics Immunology and Healthcare ETF Earnings Forecast

Key iShares Genomics Immunology and Healthcare ETF Financial Ratios

iShares Genomics Immunology and Healthcare ETF Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSEARCA
Current Symbol:	IDNA

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	0
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

IDNA Technical Analysis vs Fundamental Analysis

Buy

iShares Genomics Immunology and Healthcare ETF (IDNA) is a Buy

Is iShares Genomics Immunology and Healthcare ETF a Buy or a Sell?

iShares Genomics Immunology and Healthcare ETF stock is rated a Buy

The current iShares Genomics Immunology and Healthcare ETF [IDNA] share price is $27.01. The Score for IDNA is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.